Tandem Diabetes Care Earnings
NASDAQ: TNDMHealthcareMedical DevicesUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Next earnings date
Thu, Nov 5, 2026
After market close
Fiscal period
Sep/2026
EPS estimate
$-0.27
Tandem Diabetes Care earnings summary
Tandem Diabetes Care is scheduled to report Sep/2026 earnings on Nov 5, 2026 after the market closes, with analysts expecting EPS of $-0.27. In its most recent report on Aug 6, 2026 (Q2 2026), TNDM posted EPS of $-0.31. Revenue for the quarter was $254.6 million.
Across the last 16 reports, TNDM shares moved an average of 9.3% (in either direction) in the first trading session after results, rising 6 times and falling 10 times.
Summary generated from market data by MetaCap's automated system. Methodology
TNDM earnings history
| Report date | EPS est. | EPS actual | Surprise | Price reaction |
|---|---|---|---|---|
| Aug 6, 2026 | — | $-0.31 | — | +1.5% |
| May 7, 2026 | — | $-0.30 | — | -17.2% |
| Feb 19, 2026 | — | $-0.01 | — | +3.0% |
| Nov 6, 2025 | — | $-0.31 | — | +14.5% |
| Aug 6, 2025 | — | $-0.78 | — | -3.7% |
| Apr 30, 2025 | — | $-1.97 | — | +7.0% |
| Feb 26, 2025 | — | $0.01 | — | -18.9% |
| Nov 6, 2024 | — | $-0.35 | — | -10.7% |
| Aug 1, 2024 | — | $-0.47 | — | -10.0% |
| May 2, 2024 | — | $-0.65 | — | -0.8% |
| Feb 21, 2024 | — | $-0.46 | — | -5.3% |
| Nov 1, 2023 | — | $-0.51 | — | -9.3% |
| Aug 3, 2023 | — | $-0.55 | — | -14.9% |
| May 3, 2023 | — | $-1.92 | — | -6.0% |
| Feb 22, 2023 | — | $-0.25 | — | +14.3% |
| Nov 2, 2022 | — | $-0.76 | — | +11.4% |
Surprise compares reported EPS with the consensus estimate. Price reaction is the close-to-close move in the first session after the report. Learn about the earnings surprise.